Cornercap Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.46M | Sell |
58,478
-800
| -1% | -$20.2K | 0.72% | 64 |
|
|
2025
Q3 | $1.51M | Sell |
59,278
-1,000
| -2% | -$24.7K | 0.75% | 60 |
|
|
2025
Q2 | $1.46M | Sell |
60,278
-1,407
| -2% | -$32.8K | 0.76% | 56 |
|
|
2025
Q1 | $1.56M | Sell |
61,685
-712
| -1% | -$18.6K | 0.82% | 44 |
|
|
2024
Q4 | $1.66M | Buy |
+62,397
| New | +$1.69M | 0.53% | 27 |
|
|
2023
Q4 | – | Sell |
-74,973
| Closed | -$2.49M | – | 636 |
|
|
2023
Q3 | $2.49M | Sell |
74,973
-9,264
| -11% | -$328K | 0.45% | 27 |
|
|
2023
Q2 | $3.09M | Sell |
84,237
-4,640
| -5% | -$181K | 0.54% | 16 |
|
|
2023
Q1 | $3.63M | Buy |
88,877
+687
| +0.8% | +$29.7K | 0.64% | 10 |
|
|
2022
Q4 | $4.52M | Buy |
88,190
+425
| +0.5% | +$20.4K | 0.78% | 6 |
|
|
2022
Q3 | $3.84M | Sell |
87,765
-1,035
| -1% | -$50.3K | 0.72% | 10 |
|
|
2022
Q2 | $4.66M | Buy |
88,800
+1,553
| +2% | +$79.1K | 0.81% | 5 |
|
|
2022
Q1 | $4.52M | Sell |
87,247
-848
| -1% | -$44K | 0.5% | 20 |
|
|
2021
Q4 | $5.2M | Sell |
88,095
-1,286
| -1% | -$63.7K | 0.75% | 5 |
|
|
2021
Q3 | $3.84M | Buy |
89,381
+23,473
| +36% | +$1.04M | 0.44% | 31 |
|
|
2021
Q2 | $2.58M | Buy |
65,908
+5,916
| +10% | +$230K | 0.29% | 89 |
|
|
2021
Q1 | $2.17M | Sell |
59,992
-34,343
| -36% | -$1.22M | 0.24% | 109 |
|
|
2020
Q4 | $3.7M | Buy |
94,335
+27,816
| +42% | +$1.02M | 0.53% | 46 |
|
|
2020
Q3 | $2.32M | Buy |
66,519
+8,936
| +16% | +$313K | 0.33% | 104 |
|
|
2020
Q2 | $1.79M | Buy |
+57,583
| New | +$1.96M | 0.29% | 108 |
|
|
2020
Q1 | – | Sell |
-114,584
| Closed | -$4.26M | – | 445 |
|
|
2019
Q4 | $4.26M | Sell |
114,584
-1,005
| -0.9% | -$35.8K | 0.57% | 42 |
|
|
2019
Q3 | $3.94M | Sell |
115,589
-3,065
| -3% | -$111K | 0.56% | 46 |
|
|
2019
Q2 | $4.88M | Buy |
118,654
+1,050
| +0.9% | +$41.7K | 0.64% | 26 |
|
|
2019
Q1 | $4.74M | Sell |
117,604
-3,690
| -3% | -$148K | 0.66% | 27 |
|
|
2018
Q4 | $5.02M | Sell |
121,294
-6,398
| -5% | -$266K | 0.78% | 17 |
|
|
2018
Q3 | $5.34M | Sell |
127,692
-2,683
| -2% | -$103K | 0.7% | 30 |
|
|
2018
Q2 | $4.49M | Buy |
130,375
+6,619
| +5% | +$226K | 0.64% | 46 |
|
|
2018
Q1 | $4.17M | Buy |
123,756
+13,679
| +12% | +$470K | 0.59% | 54 |
|
|
2017
Q4 | $3.78M | Buy |
110,077
+7,110
| +7% | +$242K | 0.52% | 65 |
|
|
2017
Q3 | $3.49M | Buy |
102,967
+4,126
| +4% | +$133K | 0.49% | 71 |
|
|
2017
Q2 | $3.15M | Buy |
98,841
+19,120
| +24% | +$603K | 0.53% | 73 |
|
|
2017
Q1 | $2.59M | Buy |
79,721
+21,612
| +37% | +$681K | 0.44% | 81 |
|
|
2016
Q4 | $1.79M | Buy |
58,109
+37,485
| +182% | +$1.14M | 0.31% | 98 |
|
|
2016
Q3 | $663K | Buy |
+20,624
| New | +$690K | 0.12% | 164 |
|
|
2016
Q1 | – | Sell |
-16,466
| Closed | -$504K | – | 383 |
|
|
2015
Q4 | $504K | Buy |
+16,466
| New | +$518K | 0.1% | 162 |
|
Other funds holding PFE
Cornercap Investment Counsel's PFE Position: Q4 2025 in Review
Cornercap Investment Counsel reduced its Pfizer (PFE) stake by 1.3% in Q4 2025, selling an estimated $20.2K and leaving 58,478 shares worth $1.46M. The position accounts for 0.72% of the portfolio, ranked #64.
Cornercap Investment Counsel first reported a position in PFE in Q4 2015 and has held it in 34 quarters since. The position peaked at $5.34M in Q3 2018. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Cornercap Investment Counsel held 58,478 shares of Pfizer worth $1.46M as of Q4 2025.
- Cornercap Investment Counsel sold 800 Pfizer shares in Q4 2025, an estimated $20.2K.
- Pfizer made up 0.72% of Cornercap Investment Counsel's portfolio in Q4 2025, its #64 holding.
- Cornercap Investment Counsel first reported a position in Pfizer in Q4 2015 and has held it in 34 quarters since.
- Cornercap Investment Counsel's Pfizer position peaked at $5.34M in Q3 2018.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Cornercap Investment Counsel's 13F filing for Q4 2025, filed 13 Feb 2026.